Autoimmune biotech Xencor files for a $69 million IPO – NASDAQ
|
Autoimmune biotech Xencor files for a $ 69 million IPO
NASDAQ The Monrovia, CA-based company, which was founded in 1997 and booked $ 9 million in collaboration revenue for the 12 months ended June 30, 2013, plans to list on the NASDAQ under the symbol XNCR. Xencor initially filed confidentially on September 11 … |
